1. PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer. Issue 7 (27th July 2021) Authors: Stein, Alexander; Simnica, Donjete; Schultheiß, Christoph; Scholz, Rebekka; Tintelnot, Joseph; Gökkurt, Eray; von Wenserski, Lisa; Willscher, Edith; Paschold, Lisa; Sauer, Markus; Lorenzen, Sylvie; Riera-Knorrenschild, Jorge; Depenbusch, Reinhard; Ettrich, Thomas J; Dörfel, Steffen; Al-Batran, Sa... Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 7(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pembrolizumab and maraviroc in refractory mismatch repair proficient/microsatellite-stable metastatic colorectal cancer – The PICCASSO phase I trial. (May 2022) Authors: Haag, Georg Martin; Springfeld, Christoph; Grün, Barbara; Apostolidis, Leonidas; Zschäbitz, Stefanie; Dietrich, Mareike; Berger, Anne-Katrin; Weber, Tim Frederik; Zoernig, Inka; Schaaf, Marina; Waberer, Lisa; Müller, Daniel Wilhelm; Al-Batran, Salah-Eddin; Halama, Niels; Jaeger, Dirk Journal: European journal of cancer Issue: Volume 167(2022) Page Start: 112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The synaptic vesicle protein SV31 assembles into a dimer and transports Zn2+. Issue 2 (5th December 2016) Authors: Waberer, Lisa; Henrich, Erik; Peetz, Oliver; Morgner, Nina; Dötsch, Volker; Bernhard, Frank; Volknandt, Walter Journal: Journal of neurochemistry Issue: Volume 140:Issue 2(2017) Page Start: 280 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗